Hubbry Logo
ZEUS robotic surgical systemZEUS robotic surgical systemMain
Open search
ZEUS robotic surgical system
Community hub
ZEUS robotic surgical system
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
ZEUS robotic surgical system
ZEUS robotic surgical system
ZEUS robotic surgical system
View on Wikipedia
from Wikipedia

ZEUS Robotic Surgical System
ManufacturerComputer Motion
TypeRobotic surgery

The ZEUS Robotic Surgical System (ZRSS) was a medical robot designed to assist in surgery, originally produced by the American robotics company Computer Motion. Its predecessor, AESOP, was cleared by the Food and Drug Administration in 1994 to assist surgeons in minimally invasive surgery. The ZRSS itself was cleared by the FDA seven years later, in 2001. ZEUS had three robotic arms, which were remotely controlled by the surgeon. The first arm, AESOP (Automated Endoscopic System for Optimal Positioning), was a voice-activated endoscope, allowing the surgeon to see inside the patient's body. The other two robotic arms mimicked the surgeon's movements to make precise incisions and extractions. ZEUS was discontinued in 2003, following the merger of Computer Motion with its rival Intuitive Surgical; the merged company instead developed the Da Vinci Surgical System.

History

[edit]

AESOP

[edit]

In the 1990s, Computer Motion was a leading producer of medical robotics, manufacturing systems such as the HERMES Control Center and the SOCRATES Telecollaboration System.[1] Computer Motion conducted its original research developing the AESOP arm under a NASA SBIR (Small Business Innovation Research) contract. NASA funded the research in the hope that derivatives of such technology could help service the Space Shuttle in orbit, working on parts of the shuttle where humans cannot easily access or making other delicate repairs or adjustments.[2]

AESOP was cleared for use by the FDA in 1994, and it became the first robot to assist in a surgery. AESOP's function is to maneuver an endoscope inside the patient's body during the surgery. The camera moves based on voice commands given by the surgeon.[1] Voice activation of the AESOP arm allows the surgeon to position the camera while also controlling the other two arms of the ZEUS system. The endoscope can also be controlled by a computer which allows for more precise movements and also allows the endoscope to be inserted into the patient through a smaller incision (a key component of minimally invasive surgery).

ZEUS system

[edit]

The first prototype of the ZEUS was demonstrated in 1995, and tested on animals in 1996. Two years later, in 1998, it carried out its first tubal re-anastomosis procedure, and its first coronary artery bypass surgery (CABG) procedure. By 2000, the ZEUS was equipped to hold 28 different surgical instruments, and in 2001 it received FDA approval.[3] In 2003, the ZEUS Robot Surgical System was marketed at $975,000. This was slightly cheaper than the competing Da Vinci system, which sold for $1 million.[4]

Computer Motion vs. Intuitive Surgical

[edit]

By 2000, Computer Motion had filed eight lawsuits against a rival medical robotics company, Intuitive Surgical, for allegedly infringing on Computer Motion's patents relating to robotic surgery.[5]

On March 7, 2003, Computer Motion and Intuitive Surgical merged into a single company. This was partially done to try to end the litigation between the companies, but also to combine their efforts in developing robotic surgical systems to increase the effectiveness of such technology. Soon after merging, the ZEUS was phased out in favor of Intuitive Surgical's Da Vinci system.[6]

Features

[edit]

The ZEUS was designed for minimally invasive microsurgery procedures, such as beating heart surgery and endoscopic coronary artery bypass grafting (E-CABGTM). The system was also used to initiate more complex procedures, like a mitral valve surgery IDE study.[3] The ZEUS' robotic arms not only mimic the surgeon's hand movements, but also scale down the movement, allowing the surgeon to easily make precise and small cuts.[1]

The arms also correct for tremors in a surgeon's hands, which are normal even without fatigue, though a highly trained surgeon will be able to lessen the negative effects. However, some surgeries can last for hours, in which case the surgeon's arms will get tired, and the resulting tremors from fatigue can make the surgeon create false cuts, which can be devastating during a delicate operation. To handle this, the ZEUS is designed to track and nullify these tremors while still responding to the movements/commands of the surgeon's hands.

During the surgery, the surgeon sits at the ZEUS console to control the arms. This can also lessen fatigue, because the surgeon is sitting down during the long operation rather than leaning over the patient.

The ZEUS is also able to perform remote surgery. Because the surgeon is simply controlling the robotic arms, the surgeon can sit at a ZEUS console remote from where the surgery is actually taking place, and still be able to perform the surgery.

Timeline of use

[edit]
  • December 1, 1998 – Computer Motion Inc. and United States Surgical Corp. agreed to develop and market robotic heart surgery devices using ZEUS.[7]
  • 1998 – Dr. Frank Diamiano performed the first procedure in the United States with a reanastomosis of a fallopian tube using ZEUS.[8]
  • September 24, 1999 – Dr. Boyd of London Health Sciences Centre's (LHSC) university performed the world's first robotically-assisted closed-chest beating-heart cardiac bypass operation on 60-year-old dairy farmer, John Penner, using ZEUS.[8]
  • November 22, 1999 – The first closed-chest beating-heart cardiac hybrid revascularization procedure is performed at the London, Ontario Health Sciences Centre. Dr. Douglas Boyd used Zeus to perform an endoscopic, single-vessel heart bypass surgery on a 55-year-old male patient's left anterior descending artery.[8]
  • December 9, 1999 – Dr. Ralph Damiano, Jr., of the Milton S. Hershey Medical Center at Penn State College of Medicine in Hershey performed the first robotic-assisted beating-heart bypass in the United States using ZEUS.[8]
  • October 9, 2001 – ZEUS received FDA regulatory clearance, following the FDA decision for U.S. surgeons to use a variety of instruments to perform a wide range of robotically assisted laparoscopic and thoracic procedures.[8]
  • 2003 – Following the merger of Computer Motion and Intuitive Surgical, ZEUS was phased out in favor of the Da Vinci Surgical System.

See also

[edit]

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

ZEUS robotic surgical system

View on Grokipedia
from Grokipedia
The ZEUS Robotic Surgical System (ZRSS) was a pioneering designed to enhance precision in minimally invasive through from a surgeon's console equipped with a video monitor and hand controls. Developed by Computer Motion, Inc., it consisted of three independent robotic arms mounted on the operating table: one arm for voice-controlled endoscopic positioning and two instrument arms each providing four , tremor filtering, and scalable motion ratios from 2:1 to 10:1. Introduced in 1996 as an advancement over Computer Motion's earlier endoscope holder, ZEUS integrated 2D or 3D visualization and was funded by agencies including and to enable . ZEUS marked a significant milestone in robotic-assisted history, with its first clinical applications emerging in 1998 at the for a uterine tube procedure. By 1999, it facilitated pioneering cardiovascular interventions, such as robotically assisted aortocoronary grafts in closed-chest procedures, demonstrating its utility in complex . The system's capabilities were showcased globally in "Operation Lindbergh" on September 7, 2001, when surgeons in New York performed a 54-minute transatlantic laparoscopic on a patient in , , using a high-speed fiberoptic connection with a 150-millisecond delay and no technical complications. Additional applications included reversals, pelvic dissections, and urological procedures, often highlighting improved dexterity over traditional . Despite its innovations, faced challenges including high costs—exemplified by over $1 million in telecommunications expenses for the 2001 transatlantic procedure—and limitations in haptic feedback, which relied solely on visual cues. In 2003, Computer Motion merged with , leading to the discontinuation of ZEUS development in favor of the da Vinci system, though ZEUS's legacy influenced modern robotic platforms by proving the feasibility of telesurgery and precise remote manipulation.

History

Origins with AESOP

The (Automated Endoscopic System for Optimal Positioning) robotic system was invented by Computer Motion, Inc., a company founded in 1990 in , as the first specifically designed to hold and maneuver endoscopic cameras during minimally invasive surgery. Developed with initial support from and the Defense Advanced Research Projects Agency (), AESOP addressed a key challenge in : the need for steady, precise camera control without relying on a human assistant, which often led to inconsistent views and procedural delays. The initial version, AESOP 1000, received U.S. (FDA) clearance in 1993 as a Class II , marking it as the first FDA-approved surgical robot. This model featured foot-pedal control for positioning the , allowing surgeons to adjust views hands-free while operating. By 1996, Computer Motion introduced the AESOP 2000, which incorporated voice-activation technology, enabling surgeons to issue verbal commands in natural English for camera movements, further enhancing operational efficiency and reducing physical strain. Technically, AESOP consisted of a multi-jointed with seven , providing flexible positioning comparable to a assistant's , and it integrated seamlessly with standard laparoscopic equipment such as endoscopes from various manufacturers. Early clinical evaluations demonstrated its utility in procedures like cholecystectomies, where it maintained stable visualization throughout the operation, with studies reporting successful implementation in over 90% of cases without complications attributable to the robot. AESOP's automation of camera positioning significantly reduced surgeon fatigue and improved procedural , building on prior robotic precedents like the 1985 PUMA 560 use in a CT-guided , which had contextualized the potential of robots in precision . This foundational camera-holding technology in directly informed the subsequent development of multi-arm telesurgery systems like .

Development of ZEUS

The robotic surgical system was launched in 1998 by Computer Motion, Inc., as an advanced telesurgery platform that integrated the existing voice-controlled endoscopic camera holder with two additional robotic arms dedicated to instrument manipulation, building on 's established success in providing stable visualization during minimally invasive procedures. This multi-arm configuration enabled a single surgeon to control both the endoscope and surgical tools remotely, marking a significant evolution from single-function robotic assistance to full telemanipulation. Development of emphasized enhanced precision and remote operability, featuring a console equipped with hand controllers that translated movements to the robotic arms via a master-slave architecture. The system utilized fiber-optic data transmission for low-latency , supporting telesurgery applications, while proprietary software provided motion scaling ratios ranging from 2:1 to 10:1 and to eliminate involuntary hand movements, thereby improving dexterity in confined surgical spaces. The setup included three table-mounted arms—one for the and two for instruments—allowing flexible positioning around the patient during laparoscopic interventions. The system's inaugural full robotic procedure occurred in 1998 at the , where surgeons used to perform a laparoscopic reanastomosis on a human , demonstrating its feasibility for microsurgical tasks in gynecology. This procedure involved precise suturing under robotic control, with the study reporting successful completion in a series of cases starting that year. In October 2001, the U.S. granted 510(k) clearance for as a substantially equivalent device to conventional laparoscopes, permitting its use in general and for controlling dissectors, graspers, and stabilizers during minimally invasive procedures.

Patent disputes and merger

In March 2000, Computer Motion, Inc., the developer of the robotic surgical system, filed a lawsuit against , Inc., in the U.S. District Court for the Central District of , alleging that Intuitive's infringed nine Computer Motion covering core technologies including voice control for robotic positioning and for surgical arms. In response, Intuitive Surgical, licensed under IBM's , countersued in the U.S. District Court for the District of , claiming that Computer Motion's AESOP, , and HERMES products infringed U.S. No. 6,201,984, which covers systems for augmenting endoscopic surgery through voice commands and computer-assisted control. The disputes centered on overlapping innovations, such as Computer Motion's U.S. No. 6,244,809 for motion-scaling algorithms that adjust movements for precise minimally invasive procedures. The litigation escalated through 2001 and 2002 with multiple court rulings and interferences that intensified competitive pressures. In April 2002, the U.S. and Trademark Office issued favorable decisions for Intuitive in two of three interference proceedings, invalidating key claims in Computer Motion's U.S. Nos. 5,855,583 and 5,878,193 related to robotic positioning, while upholding Intuitive's priority in the third. A July 2002 summary judgment in the court confirmed that da Vinci infringed Computer Motion's U.S. No. 6,244,809, but in December 2002, the court upheld Intuitive's infringement claims on the '984 patent, awarding $4.4 million in damages and issuing a permanent halting sales of Computer Motion's infringing and systems. These rulings, combined with ongoing appeals and cross-licensing disputes, imposed severe financial burdens on Computer Motion, pushing the company toward bankruptcy amid mounting legal costs exceeding tens of millions of dollars. The protracted legal battles culminated in a merger agreement announced on March 7, 2003, between and Computer Motion, valued at approximately $68 million in Intuitive stock, with Computer Motion shareholders receiving 0.52 shares of Intuitive per share, equating to about 32% ownership in the combined entity. The deal, approved by shareholders and completed on June 30, 2003, resolved all pending litigation by cross-licensing the disputed patents and integrating Computer Motion's technologies into portfolio. Following the merger, development and sales of the ZEUS system were phased out in favor of the da Vinci platform, consolidating the market under .

System Design

Core components

The ZEUS robotic surgical system consisted of a modular setup designed for telesurgical applications, featuring a console, multiple robotic arms, and supporting connectivity and safety mechanisms. The console provided an ergonomic interface for the operator, including dual hand controllers—typically joysticks or master grips—that allowed precise manipulation of instruments with up to four at the console level. It incorporated 3D visualization monitors using polarized glasses for stereoscopic imaging of the surgical field, enhancing during procedures. Foot pedals were integrated for functions such as clutching to disengage controllers and switching between tools, contributing to intuitive control without disrupting hand movements. The system's robotic arms formed its primary manipulators, comprising three independent units mounted to the for stability. Two arms accommodated 8 mm instruments equipped with the MicroWrist for wrist-like flexibility, each offering 7 to mimic human wrist motion and enable articulated movements within the surgical workspace. The third arm integrated the (Automated Endoscopic System for Optimal Positioning) module, a voice- or pedal-controlled unit dedicated to endoscope positioning and providing a stable endoscopic view. Connectivity relied on Ethernet-based networking to link the console and arms, supporting both local multi-room operations and remote telesurgery through fiberoptic or dedicated lines. In local setups, overall latency remained under 100 ms, primarily due to minimal mechanical and processing delays, ensuring responsive control. Safety features emphasized reliability and sterility, including collision detection sensors on the arms to prevent unintended contacts during movement. Sterile draping protocols covered the arms and instruments to uphold operating room hygiene standards.

Technical capabilities

The ZEUS robotic surgical system incorporated advanced motion scaling and filtering mechanisms to enhance surgical precision. Motion scaling allowed surgeons to adjust ratios from 1:1 to 5:1, translating larger hand movements into finer instrument manipulations for delicate procedures. Complementing this, digital tremor reduction filtered out involuntary hand s by eliminating frequencies below 6 Hz, ensuring smoother and more stable tool control. Telesurgery capabilities were a key feature, enabling remote operations over or internet connections with specific technical requirements for reliability. The system required a minimum bandwidth of 10 Mbps for high-quality video feeds, supporting latencies as low as 150 ms in fiberoptic setups to maintain real-time control. Instrument compatibility focused on proprietary tools designed for minimally invasive access, typically 8 mm in diameter, which supported essential functions like suturing, grasping, and cutting. Although ZEUS lacked direct haptic feedback, it simulated tactile sensations through enhanced visual cues, such as tissue deformation observed via the endoscopic feed, to aid surgeons in gauging force application. The centered on the , which facilitated arm and networked operation. Hermes integrated the robotic arms with peripherals like for camera control.

Surgical Applications

Initial clinical uses

The initial clinical uses of the ZEUS robotic surgical system emerged in the late 1990s, primarily in gynecology and , where it facilitated precise laparoscopic interventions in local operating rooms. These early applications demonstrated the system's potential for enhancing control in minimally invasive procedures, with ZEUS's filtration contributing to improved stability during delicate manipulations. The debut of in occurred in 1998 with the first robotic reversal, a microsurgical reanastomosis of fallopian tubes, performed at the on women seeking fertility restoration after sterilization. This gynecologic procedure, involving 10 cases, showcased ZEUS's capability for fine suturing in confined spaces, achieving successful anastomoses without intraoperative complications. By 1999–2000, expanded to , including Nissen fundoplications for , where it was used to wrap the fundus around the laparoscopically; these cases demonstrated enhanced visualization and control. Similarly, in , supported starting in 2000, with the first robot-assisted laparoscopic radical performed in , enabling precise dissection in the bed while minimizing tissue trauma. Early adoption was bolstered by clinical trials evaluating 's efficacy in routine laparoscopic surgeries. In the United States, ZEUS received FDA 510(k) clearance for general laparoscopic procedures in 2001. These trials underscored ZEUS's reliability in specialties like and gynecology, where it was preferentially applied for its motion scaling and reduced hand tremor. Proficiency with ZEUS required structured training on simulators to master console operation and instrument control, ensuring safe integration into clinical workflows. Setup times involved arm positioning and , which decreased with team experience. Overall, these initial uses established ZEUS as a tool for standard procedures, prioritizing precision over complexity in non-remote settings.

Key telesurgery milestones

The robotic surgical system achieved a landmark in telesurgery with the Lindbergh Operation on September 7, 2001, marking the first transatlantic remote procedure. French surgeon Jacques Marescaux, operating from , performed a laparoscopic on a 68-year-old female patient in , , using the ZEUS system connected via a dedicated transatlantic . The 45-minute procedure involved four incisions and the removal of the , with Marescaux controlling the ZEUS's three robotic arms—two for instruments and one for the —from a console 6,230 km (3,850 miles) away. Prior to this, facilitated intra-continental telesurgeries. In 2002, enabled cross-border Nissen fundoplication procedures between U.S. sites, demonstrating reliable for anti-reflux surgery over several hundred miles. These efforts built on earlier demonstrations, such as a 2003 series of remote Nissen fundoplications in spanning 400 km between Hamilton and North Bay, where surgeons used to complete 13 such procedures as part of the world's first telerobotic surgical service. Key technical challenges in these telesurgeries included optimizing bandwidth for real-time video transmission and implementing correction to handle potential signal interruptions. The Lindbergh Operation utilized a 10 Mbps dedicated link to transmit compressed laparoscopic video alongside robotic control signals, ensuring stable performance despite the transoceanic distance. correction protocols, including redundant data checks over 1,000 times per second, mitigated and maintained precision, while motion scaling in (typically 3:1 or 5:1) helped compensate for the 155 ms round-trip latency. All major telesurgeries reported zero intraoperative complications, with patients experiencing uneventful recoveries, underscoring the system's reliability for remote interventions. These milestones validated telesurgery's potential to extend expert care to disaster zones or rural areas lacking specialized surgeons, paving the way for broader applications in .

Legacy

Influence on modern systems

The merger between Computer Motion and in 2003 enabled the transfer of core technologies from the and AESOP systems to the da Vinci platform, significantly shaping its evolution. 's motion scaling, which allowed surgeons to amplify small hand movements for enhanced precision (at scalable ratios from 2:1 to 10:1), and tremor filtration were directly incorporated into later da Vinci models, including the da Vinci Si released in 2009. This integration improved ergonomic control and fine-motor capabilities, addressing limitations in traditional . AESOP's voice-activated endoscope positioning, a pioneering feature for hands-free camera control, influenced the conceptual framework for auxiliary robotic assistants in modern systems, though da Vinci emphasized console-based interfaces with optional voice enhancements in research extensions. ZEUS's demonstrations of telesurgery, most notably the 2001 Operation Lindbergh—the first transatlantic robotic performed across approximately 4,000 miles with minimal latency—paved the way for broader acceptance of remote surgical concepts. This milestone, conducted without complications, demonstrated the feasibility of telesurgery. Additionally, ZEUS's multi-arm modularity inspired design principles in newer systems that employ portable, independent robotic arms for flexible operating room integration. The research legacy of spans numerous peer-reviewed publications from 1998 to 2003, with studies advancing haptics for realistic force feedback and AI-assisted targeting for precise instrument guidance, laying foundational work for current robotic enhancements. These contributions, documented in over 150 citations across surgical journals, shifted focus from basic telemanipulation to in . Educationally, ZEUS facilitated training for hundreds of surgeons through more than 300 documented procedures pre-merger, establishing early certification protocols that informed industry-wide standards, such as dual-console training in . As of 2025, ZEUS continues to be referenced in surgical and historical reviews of robotic development.

Discontinuation and outcomes

Following the 2003 merger between Computer Motion and , the robotic surgical system was discontinued to consolidate resources on the da Vinci platform. Although initial merger announcements indicated that would continue to be marketed alongside da Vinci, development and commercial support ceased shortly thereafter, with the system phased out by late 2003 or early 2004. Remaining units were repurposed for research applications in academic settings for several years post-discontinuation. Economic pressures played a significant role in ZEUS's phase-out, as the system's acquisition cost ranged from approximately $1 million to $1.5 million per unit, comparable to contemporary robotic platforms, alongside annual maintenance fees of $100,000 to $150,000. These expenses, coupled with ongoing operational challenges such as the need for specialized instrumentation, limited widespread adoption. Additionally, da Vinci's advanced 3D stereoscopic visualization offered superior depth perception over ZEUS's 2D imaging, making the latter less competitive in clinical environments. Clinical applications of tapered off after 2003, with the final documented uses occurring in cardiac procedures such as robotically assisted coronary artery bypass grafting. Retrospective evaluations of procedures, including analyses of FDA adverse event reports from 2000 to 2007, highlighted benefits like enhanced precision and tremor filtration, which contributed to lower intraoperative error rates compared to manual , though specific reductions varied by procedure. However, setup times remained a drawback, averaging around 28 minutes for tasks like , exceeding those of conventional methods. As of 2025, no systems remain in active clinical service, marking the end of its operational lifecycle more than two decades after discontinuation.

References

  1. https://pmc.ncbi.nlm.nih.gov/articles/PMC10683436/
  2. https://doi.org/10.1016/j.jviscsurg.2011.04.007
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC6261744/
  4. https://spinoff.nasa.gov/spinoff2000/hm1.htm
  5. https://pmc.ncbi.nlm.nih.gov/articles/PMC1084071/
  6. https://aornjournal.onlinelibrary.wiley.com/doi/full/10.1002/aorn.13629
  7. https://pmc.ncbi.nlm.nih.gov/articles/PMC4677089/
  8. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K931783
  9. https://www.sciencedirect.com/science/article/pii/S1878788611000324
  10. https://www.researchgate.net/figure/AESOP-2000-an-acronym-for-automated-endoscopic-system-for-optimal-positioning-as-a_fig1_13482747
  11. https://www.researchgate.net/publication/8258872_The_AESOP_robot_system_in_laparoseopic_surgery_-_Increased_risk_or_advantage_for_surgeon_and_patient
  12. https://pubmed.ncbi.nlm.nih.gov/15457381/
  13. https://www.researchgate.net/publication/8927599_Rubino_F_The_Zeus_robotic_system_experimental_and_clinical_applications_Surg_Clin_N_Am_83_1305-1315
  14. https://pubmed.ncbi.nlm.nih.gov/10785235/
  15. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=k003431
  16. https://eip.com/us/latest/article/loonshot-in-medical-robotics-patent-landscape-analysis.pdf
  17. https://isrg.intuitive.com/news-releases/news-release-details/status-update-intuitive-surgical-patent-litigation-against
  18. https://www.sec.gov/Archives/edgar/data/906829/000089256903001343/a90319e10vq.htm
  19. https://isrg.intuitive.com/news-releases/news-release-details/intuitive-surgical-receives-favorable-rulings-two-three-patent
  20. https://isrg.intuitive.com/news-releases/news-release-details/intuitive-surgical-wins-prosecution-laches-phase-delaware-patent
  21. https://law.justia.com/cases/federal/district-courts/FSupp2/214/433/2439987/
  22. https://www.nytimes.com/2003/03/08/business/company-news-acquisition-unites-rival-surgical-robot-manufacturers.html
  23. https://investor.intuitivesurgical.com/news-releases/news-release-details/intuitive-surgical-and-computer-motion-close-merger-intuitive
  24. https://isrg.intuitive.com/news-releases/news-release-details/intuitive-surgical-and-computer-motion-announce-merger-agreement
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC1356187/
  26. https://pmc.ncbi.nlm.nih.gov/articles/PMC2660512/
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC9536636/
  28. https://www.researchgate.net/publication/28359625_Software_Architecture_of_a_System_for_Robotic_Surgery
  29. https://www.sciencedirect.com/science/article/abs/pii/S2210844013001317
  30. https://dspace.library.uu.nl/bitstream/handle/1874/501/full.pdf
  31. https://www.sciencedirect.com/science/article/pii/S152229420180026X
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC4087997/
  33. https://pubmed.ncbi.nlm.nih.gov/14712867/
  34. https://www.sciencedirect.com/science/article/pii/S0015028200004234
  35. https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1563-2563.2002.t01-1-02049.x
  36. https://amj.amegroups.org/article/view/6515/html
  37. https://insights.citeline.com/MT073687/ZEUS-surgical-robot-gets-US-nod/
  38. https://onlinelibrary.wiley.com/doi/full/10.1002/rcs.2409
  39. https://pubmed.ncbi.nlm.nih.gov/11574874/
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC1356984/
  41. https://pubmed.ncbi.nlm.nih.gov/11605106/
  42. https://quartr.com/insights/edge/intuitive-surgical-enhancing-surgery-with-robotic-precision
  43. http://www.cnn.com/2001/TECH/industry/09/28/telecom.surgery.idg/
  44. https://www.generalsurgerynews.com/Opinion/Article/09-21/The-History-of-Robotic-Assisted-Surgery/64651
  45. https://www.optechtcs.com/article/S1522-2942%2801%2980026-X/fulltext
  46. https://www.sermo.com/resources/robotics-in-surgery/
  47. https://aornjournal.onlinelibrary.wiley.com/doi/10.1016/j.aorn.2013.08.012
  48. https://europepmc.org/articles/pmc2978442
  49. https://pmc.ncbi.nlm.nih.gov/articles/PMC10445506/
  50. https://www.semthorcardiovascsurg.com/article/S1043-0679%2803%2970019-7/abstract
  51. https://pmc.ncbi.nlm.nih.gov/articles/PMC4838256/
Add your contribution
Related Hubs
User Avatar
No comments yet.